France· FR:67468312
VALPROATE DE SODIUM AGUETTANT 400 mg/4 ml, solution injectable
A medicinal product containing valproate de sodium, registered in France by AGUETTANT.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- VALPROATE DE SODIUM
- Manufacturer
- AGUETTANT
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093785757410 ampoule(s) en verre de 4 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Valproate de sodium in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsNatriumvalproaat Seacross 100 mg/ml oplossing voor injectie of infusieSeacross Pharma (Europe) Limited
- United StatesValproicActavis Pharma, Inc.
- United KingdomBelvo 250mg gastro-resistant tabletsConsilient Health Ltd
- CanadaAPO-DIVALPROEXAPOTEX INC
- SpainACIDO VALPROICO ALTAN 400 mg POLVO PARA SOLUCION INYECTABLE EFGAltan Pharmaceuticals S.A.
- SwitzerlandConvulex
- PolandConvulexInPharm Sp. z o.o.
- BelgiumConvulex 300 mgG.L. Pharma
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Convulex
- Bulgaria · Convulex, Конвулекс
- Czechia · Convulex
- Germany · Convulex
- Estonia · Convulex
- United Kingdom (Northern Ireland) · Convulex
- Hungary · Convulex
- Lithuania · Convulex
- Latvia · Convulex
- Poland · Convulex, Convulex 150
- Portugal · Ácido Valpróico Generis
- Romania · Convulex
- Slovakia · Convulex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2ddbe7f-e663-472e-b41b-d69b72698e5f GET /v1/drugs/b2ddbe7f-e663-472e-b41b-d69b72698e5f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67468312",
"date_amm": "2007-03-08",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "VALPROATE DE SODIUM",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about valproate de sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.